Stress & Adrenal

Best Ashwagandha for Cortisol: The Practitioner's Guide

Cortisol dysregulation is behind more fatigue, sleep disruption, and belly fat than most people realize — yet not all ashwagandha supplements are created equal. The extract form, dose, and timing all determine whether you get clinical results or expensive placebo. This guide breaks down exactly what the evidence says about the best ashwagandha for cortisol, with a focus on KSM-66, the most studied root-only extract on the market.

Jared Murray ·Co-Founder & Head of Health Research, Ones · ·8 min read
ashwagandhaKSM-66cortisoladaptogensstressadrenal support
Best Ashwagandha for Cortisol: The Practitioner's Guide

Why Cortisol Is the Root of So Many Symptoms

Cortisol gets a bad reputation, but it's not inherently harmful. It's your primary stress hormone — produced by the adrenal glands in a rhythm that should peak in the morning to wake you up and taper off by evening. The problem arises when chronic stress, poor sleep, blood sugar swings, or overtraining flatten that rhythm or keep levels elevated around the clock.

Symptoms of cortisol dysregulation include persistent fatigue that doesn't resolve with sleep, abdominal weight gain, brain fog, irritability, disrupted circadian rhythm, and blunted immune response. Over time, chronically elevated cortisol can suppress thyroid function, impair reproductive hormones, and accelerate bone loss (Tsigos & Chrousos, Journal of Endocrinology 2002; PMID: 11751106).

Ashwagandha (Withania somnifera) is one of the most rigorously studied adaptogens for this exact problem. But the term "ashwagandha" covers a range of products — from low-potency root powders to standardized extracts with documented clinical performance. Identifying the best ashwagandha for cortisol means understanding which extract, at what dose, under what conditions, actually moves the needle on your stress hormones.

---

What Makes KSM-66 the Gold Standard Extract

Not all ashwagandha extracts are equivalent. The two most studied commercial forms are KSM-66 (a full-spectrum root extract standardized to ≥5% withanolides) and Sensoril (a root-and-leaf extract standardized to ≥10% withanolides). Both have clinical trials, but KSM-66 has the deeper body of cortisol-specific evidence and is the form used in the majority of randomized controlled trials cited in this guide.

KSM-66 is extracted using a proprietary milk-based process that preserves the lipophilic withanolide fraction — the bioactive compounds that interact with the HPA axis (hypothalamic-pituitary-adrenal axis). This matters because withanolide glycosides, particularly withanoside IV and withaferin A, appear to downregulate cortisol synthesis by modulating stress-induced signaling cascades at the hypothalamic level rather than simply acting as a sedative.

For a thorough breakdown of how KSM-66 works mechanistically and what the 600 mg dose studies found, see our deep-dive on ashwagandha KSM-66 stress, cortisol, and clinical dosage.

---

The Clinical Evidence: What KSM-66 Actually Does to Cortisol

The foundational cortisol trial was conducted by Chandrasekhar et al. (2012), a double-blind, randomized, placebo-controlled study in 64 adults with a history of chronic stress. Participants received 300 mg of KSM-66 twice daily (600 mg total) for 60 days. Serum cortisol dropped by 27.9% in the ashwagandha group versus a modest, non-significant change in placebo. Stress scores on the PSS (Perceived Stress Scale) fell by 44%, and participants also reported improved sleep quality, reduced anxiety, and a sense of general well-being (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798).

A second landmark study by Choudhary et al. (2017) focused on body weight and food cravings in chronically stressed adults — two outcomes tightly linked to cortisol. The 300 mg twice-daily KSM-66 protocol over 8 weeks produced significant reductions in serum cortisol, body weight, and emotional eating scores compared to placebo (Choudhary et al., Journal of Evidence-Based Complementary & Alternative Medicine 2017; PMID: 27055824).

A 2019 study by Langade et al. specifically examined ashwagandha's effect on sleep quality — another dimension of cortisol dysregulation — using 300 mg KSM-66 twice daily over 10 weeks. The ashwagandha group showed significantly improved sleep onset latency, total sleep time, and sleep efficiency, outcomes that are partly mediated through cortisol normalization in the evening (Langade et al., Cureus 2019; PMID: 31728244).

A 2021 trial by Majeed et al. using a different extract (Shoden, standardized to 35% withanolide glycosides) at just 120 mg/day also found cortisol reduction, which supports the idea that withanolide bioavailability — not raw dose alone — drives efficacy (Majeed et al., Medicine 2021; PMID: 33726024).

Collectively, these trials establish that standardized ashwagandha at 300–600 mg per day, taken for 8–12 weeks, consistently reduces serum cortisol by 20–30% in chronically stressed adults. No comparable evidence exists for generic ashwagandha root powder without withanolide standardization.

---

KSM-66 Ashwagandha: Morning or Night?

One of the most common practitioner questions is whether to take KSM-66 in the morning, at night, or split across both. The short answer: split dosing (morning + evening) matches the trial protocols that produced the strongest results, and it makes physiological sense.

Cortisol follows a diurnal rhythm — the cortisol awakening response (CAR) peaks 30–45 minutes after waking and is the period when the HPA axis is most active. Taking a dose in the morning works with this window, supporting a healthy stress response throughout the day. An evening dose coincides with the need to wind cortisol down, which supports sleep quality and recovery — consistent with the Langade 2019 trial findings.

If a single daily dose is preferred (some people simplify their stack), the evening is often better tolerated from a subjective standpoint because ashwagandha's calming, GABA-modulating properties can feel mildly sedating in sensitive individuals. However, in the Chandrasekhar 2012 trial, split dosing with 300 mg morning and 300 mg evening produced the 27.9% cortisol reduction — making this the most evidence-backed protocol.

For a broader look at how morning cortisol elevation can be addressed through supplementation, our article on supplements for high morning cortisol covers additional interventions worth pairing.

---

KSM-66 Ashwagandha With Food or Empty Stomach?

This is a practical question with a clinically meaningful answer. Ashwagandha's active withanolides are lipophilic — they dissolve in fat rather than water. This means absorption is meaningfully enhanced when taken with a meal that contains some dietary fat.

In the Chandrasekhar 2012 trial, capsules were taken with meals. No major trial has specifically compared fasted versus fed absorption of KSM-66, but the lipophilic pharmacology strongly supports taking it with food. Practically:

  • With a fat-containing meal: better withanolide absorption, reduced risk of GI upset
  • On an empty stomach: some users report mild nausea or GI discomfort, and theoretical absorption is lower due to the absence of fat-mediated micellar solubilization

A small subset of users are highly sensitive to ashwagandha on an empty stomach and report abdominal cramping or loose stools. This is believed to be related to the alkaloid fraction of the extract acting on gut motility receptors. Taking KSM-66 with a meal containing 10–15 grams of fat is the standard recommendation in integrative medicine practice.

If you're navigating similar absorption questions for other supplements, our piece on zinc picolinate — with food or empty stomach uses the same framework to evaluate timing.

---

KSM-66 Ashwagandha Benefits Beyond Cortisol

While cortisol reduction is the primary indication in most clinical trials, the downstream benefits of HPA axis normalization ripple across multiple systems:

Thyroid function: Some studies suggest ashwagandha mildly elevates T3 and T4 in subclinical hypothyroidism. A 2018 randomized controlled trial in 50 patients with subclinical hypothyroidism found that 600 mg/day of ashwagandha root extract over 8 weeks significantly improved T3, T4, and TSH compared to placebo (Sharma et al., Journal of Alternative and Complementary Medicine 2018; PMID: 29190457). This is relevant because elevated cortisol is a well-known suppressor of thyroid hormone conversion.

Testosterone and reproductive hormones: In men, chronic cortisol elevation suppresses LH and testosterone. Several trials with KSM-66 have shown modest but statistically significant increases in serum testosterone, likely mediated by cortisol reduction rather than a direct androgenic mechanism.

Muscle recovery and body composition: Ashwagandha's anti-catabolic effect — reducing cortisol-driven muscle protein breakdown — supports lean mass retention during stress or intensive training.

Cognitive performance: Cortisol chronically impairs hippocampal function and working memory. Reducing cortisol through adaptogenic support has shown measurable improvements in reaction time, cognitive flexibility, and memory recall in stressed adults.

Benefit DomainMechanismEvidence Level
Cortisol reductionHPA axis downregulationHigh (multiple RCTs)
Sleep qualityCortisol normalization + GABA modulationModerate (2 RCTs)
Thyroid supportT3/T4 upregulationModerate (1 RCT)
TestosteroneLH axis normalizationModerate (2 RCTs)
Muscle recoveryReduced cortisol catabolismModerate
Cognitive functionHippocampal cortisol reductionLow-moderate

For a practitioner-level overview of how ashwagandha addresses the cortisol axis specifically, see the practitioner's guide to ashwagandha for cortisol.

---

KSM-66 Ashwagandha Side Effects: What the Trials Report

Across the major clinical trials, KSM-66 at 300–600 mg/day has a favorable safety profile. Adverse events reported were generally mild, transient, and no different from placebo in most blinded comparisons. That said, practitioners should be aware of the following:

Thyroid overstimulation: Because ashwagandha can raise T3 and T4, individuals already on thyroid hormone replacement or with hyperthyroidism should use caution and monitor labs. This is the most clinically relevant contraindication.

GI discomfort: Nausea and loose stools are occasionally reported, especially on an empty stomach or at doses above 600 mg. Taking with food resolves this in most cases.

Autoimmune conditions: Ashwagandha's immunomodulatory properties mean it is theoretically contraindicated in active autoimmune flares. Clinical guidance from integrative practitioners suggests avoiding it in active lupus, rheumatoid arthritis exacerbation, or Hashimoto's thyroiditis without practitioner oversight.

Sedation and medication interactions: Ashwagandha potentiates GABA-A receptor activity. Combining it with benzodiazepines, sedatives, or alcohol may produce additive CNS depression. Most patients on standard dosing do not experience clinical sedation, but sensitive individuals (particularly those already using sleep aids) should start at 300 mg and assess response.

Pregnancy: Ashwagandha has uterotonic properties documented in animal studies. It is generally contraindicated during pregnancy.

Liver toxicity has been reported in rare case reports linked to high-dose or non-standardized ashwagandha products (not KSM-66 specifically), but the signal exists. Anyone with elevated liver enzymes should use caution. See our article on orlistat side effects and functional medicine support for context on how liver-related supplement concerns are typically evaluated in an integrative framework.

---

What This Means for Your Formula

At Ones, ashwagandha isn't recommended universally — it's included in a personalized formula when your intake data, lab markers (morning cortisol, DHEA-S ratio, sleep data from wearables), and stress history indicate HPA axis dysregulation. When included, Ones uses KSM-66 at 600 mg — the exact standardized extract and dose validated in the Chandrasekhar 2012 and Choudhary 2017 trials.

For clients with broader adrenal dysregulation patterns — particularly those showing morning cortisol elevation, disrupted sleep-wake cycles, or wearable-detected low HRV — Ones may also include the proprietary Adrenal Support System Blend, which pairs adaptogenic and adrenal-specific nutrients in a calibrated, multi-ingredient format. This combination approach recognizes that cortisol dysregulation is rarely a single-pathway problem.

Individuals with co-occurring subclinical hypothyroid markers may also have Thyroid Support incorporated, given ashwagandha's documented influence on T3/T4 and the frequent overlap between cortisol and thyroid dysfunction. The AI practitioner at Ones weighs these interactions before finalizing which ingredients make it into your capsule plan.

The Ones model doesn't let you simply add KSM-66 to a cart. Instead, the AI evaluates whether your cortisol picture actually warrants it — and at which dose — based on your specific data. This prevents unnecessary supplementation and ensures the ingredients that do make your formula are there for a reason.

---

Key Takeaways

  • KSM-66 is the best-evidenced ashwagandha for cortisol, with multiple randomized controlled trials showing 20–30% serum cortisol reduction at 600 mg/day over 8–12 weeks.
  • Split dosing (300 mg morning + 300 mg evening) matches the strongest clinical protocols and aligns with cortisol's natural diurnal rhythm.
  • Take KSM-66 with food, ideally containing dietary fat, to optimize withanolide absorption and minimize GI discomfort.
  • Benefits extend beyond cortisol to include sleep quality, thyroid support, testosterone normalization, and cognitive performance — all downstream of HPA axis regulation.
  • Side effects are generally mild but clinically relevant exceptions include thyroid conditions, autoimmune disease, pregnancy, and concurrent use of sedative medications.
  • Personalized supplementation matters: whether KSM-66 belongs in your formula depends on your cortisol data, not a generic stress checklist — which is why Ones uses lab and wearable inputs before prescribing it.

Written by Jared Murray, Co-Founder & Head of Health Research, Ones.

Jared is the co-founder and head of health research at Ones, with 25 years applying nutrition science, biomarker interpretation, and clinical supplementation research to individual health programs. He leads the editorial process for the Ones Health Library, where lab data, wearable biometrics, and peer-reviewed clinical research are translated into evidence-based, personalized supplement guidance.

Disclosure: Ones formulates and sells personalized supplements that may include ingredients discussed in this article. We have a financial interest in the products mentioned. Recommendations are based on published research and our editorial standards, not sales targets.

This article is educational content, not medical advice. Consult a healthcare provider before changing your supplement regimen.

Further reading

Related reading